Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Iwona Auer"'
Publikováno v:
Cytometry Part B: Clinical Cytometry. 100:574-589
Background Flow cytometry immunophenotyping (FCIP) can improve diagnosis of myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN), although its application is challenging due to difficulties in standardization, co
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 47:382-388
Flow cytometry of the cerebrospinal fluid (CSF) is used in isolation or as an adjunct to cytology to increase the sensitivity of detecting primary central nervous system (CNS) lymphoma. We aim to evaluate the sensitivity of CSF flow cytometry as a di
Publikováno v:
JAAD Case Reports
Posttransplant lymphoproliferative disorder (PTLD) describes a varied group of lymphoid proliferative processes that affect immunosuppressed solid organ and bone marrow transplant recipients. Approximately 70% of PTLD cases are related to Epstein-Bar
Publikováno v:
McMaster University Medical Journal. 16:1-5
Kikuchi-Fujimoto disease is a rare, self-limited, histiocytic necrotizing lymphadenitis characterized by cervical lymphadenopathy and fever. An association has been made between the presence of this disease and systemic lupus erythematosus. We descri
Publikováno v:
Cytometry. Part B, Clinical Cytometry
Background Flow cytometry immunophenotyping (FCIP) can improve diagnosis of myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN), although its application is challenging due to difficulties in standardization, co
Publikováno v:
International Journal of Surgical Pathology. :106689692098162
Follicular dendritic cell sarcoma is a rare malignant mesenchymal neoplasm composed of follicular dendritic cells. A subset of cases can be found at extranodal sites. Only 2 follicular dendritic cell sarcomas were previously reported in the urinary b
Autor:
Poonam Dharmani-Khan, Douglas A. Stewart, Adnan Mansoor, James A. Russell, Kareem Jamani, Jan Storek, Mette Hoegh-Petersen, Yiping Liu, Peter Podgorny, Tyler Williamson, Laura M. Pratt, Joanne Luider, Faisal Khan, Andrew Daly, Alejandra Ugarte-Torres, Iwona Auer-Grzesiak
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(4):450-462
Graft-versus-host disease (GVHD) is a major transplantation complication. The purpose of this study was to measure immune cell subsets by flow cytometry early after transplantation (before median day of GVHD onset) to identify subsets that may play a
Autor:
Douglas A. Stewart, Joanne Luider, James A. Russell, Laura M. Hagel, Mette Hoegh-Petersen, Iwona Auer-Grzesiak, Yiping Liu, Mark Bosch, Manveer Dhadda, Adnan Mansoor, Michael Boeckh, Faisal Khan, David G. Maloney, Jan Storek, Peter Podgorny, Andrew Daly, Alejandra Ugarte-Torres
Publikováno v:
Cytotherapy. 14:1258-1275
Background aims Anti-thymocyte globulin (ATG) is being used increasingly to prevent graft-versus-host disease (GvHD); however, its impact on immune reconstitution is relatively unknown. We (i) studied immune reconstitution after ATG-conditioned hemat
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45:S27-S27
Background: Flow cytometry in the cerebrospinal fluid (CSF) is used as an adjunct to cytology to increase the sensitivity of detecting central nervous system (CNS) lymphoma. We aim to evaluate CSF flow cytometry as a diagnostic tool for lymphoma in p
Autor:
Tyler Williamson, Jan Storek, James A. Russell, Iwona Auer-Grzesiak, Andrew Daly, Laura M. Pratt, Poonam Dharmani-Khan, Peter Podgorny, Adnan Mansoor, Yiping Liu, Joanne Luider, Victor H Jimenez-Zepeda, Loree Larratt, Faisal Khan, Alejandra Ugarte-Torres, Mette Hoegh-Petersen, Douglas A. Stewart
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(1)
Hematopoietic cell transplant (HCT) recipients are immunocompromised and thus predisposed to infections. We set out to determine the deficiency of which immune cell subset(s) may predispose to postengraftment infections. We determined day 28, 56, 84,